0001225208-22-003465.txt : 20220225 0001225208-22-003465.hdr.sgml : 20220225 20220225174638 ACCESSION NUMBER: 0001225208-22-003465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220223 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAMICO JENNIFER B. CENTRAL INDEX KEY: 0001805617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 22682516 MAIL ADDRESS: STREET 1: C/O PFIZER INC. CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2022-02-23 0000078003 PFIZER INC PFE 0001805617 DAMICO JENNIFER B. PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 SVP & Controller Common Stock 2022-02-23 4 M 0 11748.0000 27.3400 A 21668.0000 D Common Stock 2022-02-23 4 F 0 2339.0000 46.8700 D 19329.0000 D Common Stock 2022-02-23 4 F 0 5815.0000 51.2800 D 13514.0000 D Common Stock 2022-02-24 4 A 0 2893.0000 0.0000 A 16407.0000 D Stock Appreciation Rights 27.3400 2022-02-23 4 M 0 11748.0000 0.0000 D 2022-02-23 2022-02-23 Common Stock 11748.0000 0.0000 D Stock Appreciation Rights 45.9600 2022-02-24 4 A 0 11623.0000 0.0000 A 2027-02-24 2027-02-24 Common Stock 11623.0000 11623.0000 D Stock Appreciation Rights 45.9600 2022-02-24 4 A 0 10222.0000 0.0000 A 2029-02-24 2029-02-24 Common Stock 10222.0000 10222.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Susan E. Grant, by power of atty., for Jennifer B. Damico 2022-02-25